Your browser doesn't support javascript.
loading
The Level of Anti-Polyethylene Glycol (PEG) Immunoglobulin G Antibodies in Human Serum Does Not Correlate with Efficiency of PEGylated Nanoparticle Uptake by Monocytes.
Nevskaya, K V; Krivoshchekov, S V; Zima, A P; Baikov, A N; Gur'ev, A M; Pershina, A G.
Afiliação
  • Nevskaya KV; Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia.
  • Krivoshchekov SV; Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia.
  • Zima AP; Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia.
  • Baikov AN; Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia.
  • Gur'ev AM; Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia.
  • Pershina AG; Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia. allysyz@mail.ru.
Bull Exp Biol Med ; 175(2): 270-274, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37466857
ABSTRACT
The presence of anti-polyethylene glycol (PEG) antibodies can limit the clinical efficacy of PEGylated drugs and cause anaphylactic reactions in patients. Monocytes/macrophages are effector cells involved in IgG-mediated passive systemic anaphylaxis. We studied the influence of human blood serum on the efficiency of uptake of PEGylated nanoparticles by human blood monocytes. It has been shown that magnetic nanoparticles modified with PEG-3000 and solid lipid nanoparticles containing PEG-2000 are avidly internalized by human blood monocytes in vitro, the uptake efficiency depends on the features (composition) of donor blood serum, but does not correlate with the level of the IgG antibody against PEG.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Soro / Nanopartículas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Soro / Nanopartículas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article